Charles F. Wagner Jr. - 01 Apr 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
01 Apr 2022
Net transactions value
-$683,602
Form type
4
Filing time
05 Apr 2022, 16:06:05 UTC
Previous filing
21 Mar 2022
Next filing
03 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $78,426 -300 -0.65% $261.42 45,902 01 Apr 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $100,458 -381 -0.83% $263.67 45,521 01 Apr 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $302,699 -1,142 -2.5% $265.06 44,379 01 Apr 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $142,549 -536 -1.2% $265.95 43,843 01 Apr 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale $59,470 -223 -0.51% $266.68 43,620 01 Apr 2022 Direct F1, F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1.
F2 Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $261.42 (range $261.04 to $261.80).
F4 Open market sales reported on this line occurred at a weighted average price of $263.67 (range $263.45 to $264.42).
F5 Open market sales reported on this line occurred at a weighted average price of $265.06 (range $264.53 to $265.48).
F6 Open market sales reported on this line occurred at a weighted average price of $265.95 (range $265.55 to $266.47).
F7 Open market sales reported on this line occurred at a weighted average price of $266.68 (range $266.55 to $266.83).